Antisense oligonucleotides for in vivo studies of angiotensin receptors

Advances in Experimental Medicine and Biology

Volumn 396, Issue , 1996, Pages 79-92

  Phillips, M Ian ^a   Ambühl, Philipp ^a   Gyurko, Robert ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; DRUG RECEPTOR BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE ACTIVITY; GENE EXPRESSION; GENETIC CODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; REVIEW; RNA SEQUENCE; RNA TRANSLATION; TARGET CELL;

EID: 0030004699     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1376-0_9     Document Type: Review

References (42)

1. Stull, R.A., Taylor, L.A. and Szoka, F.C., Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices, Nucl.Acids Res., 20(13) (1992) 3501-3508.
2. Cowsert, L.M., Fox, M.C., Zon, G. and Mirabelli, C.K., in vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts, Antimicrob. Agents Chemother. 37(2) (1993) 171-177.
3. Wakita, T. and Wands, J.R., Specific inhibition of hepatitis C virus expression by antisense oligonucleotides. In vitro model for selection of target sequence, J.Biol.Chem., 269(19) (1994) 14205-14210.
4. Lima, W.F., Monia, B.P., Ecker, D.J. and Freier, S.M., Implication of RNA structure on antisense oligonucleotide hybridization kinetics, Biochemistry 31(48) (1992) 12055-12061.
5. Rittner, K and Sczakiel, G., Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1, Nucl.Acid Res., 19(7) (1991) 1421-1426.
6. Jaroszevski, J.W., Syi, J.L., Ghosh, M., Ghosh, K. and Cohen, J.S., Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding, Antisense Res.Dev., 3(4) (1993) 339-348.
7. Fakler, B., Herlitze, S., Amthor, B., Zenner, H.P. and Ruppersberg, J.P., Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent of location of the target sequence, J.Biol.Chem., 269(23) (1994) 16187-16194.
8. Puskas, L.G. and Bottka, S., Prokaryotic test system for evaluation of oligonucleotide-affected antisense inhibition, Anal.Biochem., 222(2) (1994) 305-309.
9. Singer, M. and Berg, P. In. Genes and Genomes, University Science Books, 54-59.
10. Iversen, P.L., Zhu, S., Meyer, A. and Zon, G., Cellular uptake and subcdellular distribution of phosphorothioate oligonucleotides into cultured cells, Antisense Res.Dev., 2(3) (1992) 211-222.
11. Colige, A., Sokolov, B.P., Nugent, P., Baserge, R. and Prockop, D.J., Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COLIA1) in transfected mouse 3T3 cells, Biochemistry, 32(1) (1993) 7-11.
12. Helene, C., The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides, Anticancer Drug Res., 6(6) (1991) 569-584.
13. Bennett, C.F., Condon, T.P., Grimm, S., Chan, H. and Chiang, M.Y., Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides, J.Immunol., 152(7) (1994) 3530-3540.
14. Bacon, T.A. and Wickstrom, E., Walking along human c-myc mRNA with antisense oligonucleotides: maximum efficacy at the 5′ cap region, Oncogene Res., 6(1) (1991) 13-19.
15. Campbell, J.M. Bacon, T.A. and Wickstrom, E., Oligodeoxynucleotide phosphorothioate stability in subcellular extracts, culture media, ser and cerebrospinal fluid, J. Biochem. Biophys. Methods 20(3) (1990) 259-267.
16. Wahlestedt, C., Antisense oligonucleotide strategies in neuropharmacology, TiPS, 15 (1994) 42-46.
17. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49(2) (1993) 167-74.
18. Gyurko, R., Li, B., Sumners, C. and Phillips, M.I., Antisense inhibition of angiotensin type-1 receptor expression in NG108-15 cells, Soc. for Neurosci. (1994) 220.7
19. Li, B. and Phillips, M.I., Cellular uptake of oligonucleotides in bovine adrenal cells (in press) (1995).
20. Yu, C., Brussaard, A.B., Yang, X., Listerud, M. and Role, L.W., Uptake of antisense oligonucleotides and functional block of acetylcholine receptor subunit gene expression in primary embryonic neurons. Dev-Genet 14(4) (1993) 296-304.
21. Marti, G., Egan, W. Noguichi, P. Zon, G., Matsukura, M. and Broder, S., Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells, Antisense Res. Rev. 2(1) (1992) 27-39.
22. Clarenc, J.P., LeBleu, B. and Leonetti, J.P., Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs, J. Biol. Chem. 268(8) (1993) 5600-5604.
23. Sixou, S., Szoka, F.C., Jr., Green, G.A., Giusti, B., Zong, G. and Chin, D.J., Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET), Nuclei Acids Res. 22(4) (1994) 662-668.
24. Temsamani, J., Kubert, M., Tang, J., Padmapriya, A., Agrawal, S., Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs, Antisense Res. Dev. 4(1) (1994) 35-42.
25. Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C.E., Reis, D.J., Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions, Nature 363(6426) (1993) 260-263.
26. Rougee, M., Faucon, B., Mergny, J.L., Barcelo, F., Giovannangeli, C., Garestier, T., Helene, C., Kinetics and thermodynamics of triple-helix formation: effects of ionic strength and mismatches, Biochemistry 31 (1992) 9269-9278.
27. Crooke, R.M., In vitro toxicology and pharmacokinetics of antisense oligonucleotides, Anticancer Drug Des. 6(6) (1991) 609-646.
28. Phillips, M.L. Wielbo, D. and Gyurko, R., Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genes, Kidney Intl. 46 (1994) 1554-1556.
29. Wielbo, D., Sernia, C., Gyurko, R. and Phillips, M.I., Antisense inhibition of hypertension in the spontaneously hypertensive rat, Hypertension 25 (1994) 314-319.
30. Phillips, M.I., Functions of angiotensin II in the central nervous system, Ann. Rev. Physiol. 49 (1985) 413-415.
31. 1 receptor antisense oligonucleotide inhibits the behavioral actions of angiotensin II, J. Neurochem. 62 (1994) 2053-2056.
32. 1 receptor mRNA antisense oligonucleotide inhibits central angiotensin induced thirst and vasopressin, Regul. Pept. 54 (1994) 543-551.
33. 1 receptor (in press) (1995).
34. Kakar, S.S., Riel, K.K. and Neill, J.D., Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brain, Biochem. Biophys. Res. Commun., 185 (1992) 688-692.
35. 1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control, Mol. Brain Res., 30 (1995) 53-60.
36. Morishita, R., Gibbons, G.H., Kaneda, Y., Ogihara, T. and Dzau, V.J., Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery, Gene 149(1) (1994) 13-19.
37. Kaneda, Y., Iwai, K. and Uchida, T., Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Science 243 (1989) 375-378.
38. Stein, C.A. and Krieg, A.M., Problems in interpretation of data derived from in vivo and in vivo use of antisense oligodeoxynucleotides (Editorial), Antisense Rev. Dev. 4 (1994) 67-69.
39. Muzyczka, N., Use of adeno-associated virus as a general transduction vector for mammalian cells, Curr. Top Microbiol. Immunol. 158 (1992) 97-129.
40. Ponnazhagan, S., Nallari, M.L. Srivastava, A., Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors, J. Exp. Med. 179(2) (1994) 733-738.
41. Chatterjee, S., Johnson, P.R., Wong, K.K., Jr., Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector, Science 258 (1992) 1485-1488.
42. Caulfield, M., Lavender, P., Farrell, M., Munroe, P., Lawson, M., Turner, P., Clark, A., Linkage of angiotensinogen gene to essential hypertension, New Eng. J. Med. 330 (1994) 1629-1633.